Rchr
J-GLOBAL ID：201801019969107520
Update date: Dec. 09, 2024
Nishiwaki Satoshi
Nishiwaki Satoshi
Research field (1)：
Hematology and oncology
Research theme for competitive and other funds (2)：
- 2020 - 2023 Multilateral prognostic factor analysis for Ph+ALL in the era of TKI
- 2017 - 2021 Significance of BCR gene breakpoint in Ph + ALL
Papers (65)：
-
Tomoyasu Jo, Kosuke Inoue, Tomoaki Ueda, Makoto Iwasaki, Yu Akahoshi, Satoshi Nishiwaki, Hiroki Hatsusawa, Tetsuya Nishida, Naoyuki Uchida, Ayumu Ito, et al. Machine learning evaluation of intensified conditioning on haematopoietic stem cell transplantation in adult acute lymphoblastic leukemia patients. Communications Medicine. 2024. 4. 1
-
Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, Yoshihiro Hatta, Yoshiko Atsuta, Noriko Doki, Shingo Kurahashi, Yasunori Ueda, Nobuaki Dobashi, Tomoya Maeda, et al. Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission. American journal of hematology. 2024. 99. 5. 806-815
-
Hisashi Ishida, Yuki Arakawa, Daiichiro Hasegawa, Ikuya Usami, Yoshiko Hashii, Yasuyuki Arai, Satoshi Nishiwaki, Dai Keino, Keisuke Kato, Maho Sato, et al. Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia. Annals of hematology. 2023
-
Shigeki Hirabayashi, Tadakazu Kondo, Satoshi Nishiwaki, Shuichi Mizuta, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Ryota Imanaka, et al. Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ALL: A retrospective nationwide study. American Journal of Hematology. 2023
-
Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, Yoshihiro Hatta, Yoshiko Atsuta, Noriko Doki, Shingo Kurahashi, Yasunori Ueda, Nobuaki Dobashi, Tomoya Maeda, et al. High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study. HemaSphere. 2023. 7. 6. e899
ｍore...
MISC (16)：
-
Isamu Sugiura, Noriko Doki, Tomoko Hata, Ryuko Cho, Toshiro Ito, Youko Suehiro, Heiwa Kanamori, Shinichi Kako, Mitsuhiro Matsuda, Hisayuki Yokoyama, et al. Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study. BLOOD. 2019. 134
-
Satoshi Nishiwaki, Yuichi Ando. Application of the new process for unapproved drug use: Dilemma of universal health care coverage in Japan. Journal of Global Oncology. 2019. 2019. 5
-
Keiki Sugimoto, Yasuhiko Miyata, Takayuki Nakayama, Shigeki Saito, Ritsuro Suzuki, Fumihiko Hayakawa, Satoshi Nishiwaki, Hiroki Mizuno, Kyosuke Takeshita, Hidefumi Kato, et al. Fibroblast Growth Factor-2 facilitates the growth and chemoresistance of leukemia cells in the bone marrow by modulating osteoblast functions. SCIENTIFIC REPORTS. 2016. 6. 30779
-
Hiroki Mizuno, Takayuki Nakayama, Yasuhiko Miyata, Shigeki Saito, Nishiwaki Satoshi, Norihiko Nakao, Kyosuke Takeshita, Akihiro Tomita, Tomoki Naoe. Mast Cells As a Therapeutic Target for Hodgkin Lymphoma: Bortezomib Inhibits Mast Cell-Induced Modification of the Tumor Microenvironment. BLOOD. 2012. 120. 21
-
Junji Tanaka, Kanamori Heiwa, Nishiwaki Satoshi, Ohashi Kazuteru, Taniguchi Shuichi, Eto Tetsuya, Nakamae Hirohisa, Yoshio Katayama, Yasuo Morishima, Ritsuro Suzuki, et al. Reduced-Intensity Versus Myeloablative Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 45 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). BLOOD. 2012. 120. 21
ｍore...
Awards (5)：
- 2015/11 - 日本白血病研究基金 一般研究賞
- 2012/06 - 2012 ASCO Annual Meeting Merit Award
- 2011/07 - 名古屋大学学術奨励賞
- 2008/11 - 日本白血病研究基金 一般研究賞 (日本臨床血液学会推薦)
- 2008/02 - 第30回日本造血細胞移植学会奨励賞
Return to Previous Page
